Carisma Therapeutics Inc.
CARMDelisted Dec 15, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001485003
Carisma Therapeutics Inc. was delisted on Dec 15, 2025; its insiders filed their last Form 4 on Oct 8, 2025; 33 institutions reported holding it in 13F filings for Q3 2025, worth $842.6K in total; no superinvestor held it.
Q3 2025 vs. Q2 2025
How the institutions holding Carisma Therapeutics Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 36 | 33 | −3 |
| Shares | 3.98M | 3.08M | −906.5K (−22.8%) |
| Value | $1.56M | $842.6K | −$714.4K (−45.9%) |
New holders (3)
Institutions that held Carisma Therapeutics Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Virtu Financial LLC | 22,854 | $6.00K | 0.00% |
| Citigroup Inc | 11,274 | $3.09K | 0.00% |
| Royal Bank of Canada | 32 | $0 | 0.00% |
Sold out (6)
Institutions that held Carisma Therapeutics Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| AJU IB Investment Co., Ltd. | 718,332 | $281.3K |
| Jane Street Group, LLC | 150,810 | $59.1K |
| Baader Bank INC | 18,404 | $4.45K |
| Bank & Trust Co | 525 | $206 |
| Barclays PLC | 100 | $39 |
| Raymond James Financial Inc | 75 | $29 |